CN Patent

CN111909256A — 多肽衍生物及其制备方法

Assigned to Ningbo Kunpeng Biotech Co Ltd · Expires 2020-11-10 · 6y expired

What this patent protects

本发明提供了多肽衍生物及其制备方法。具体地，本发明提供了一种多肽衍生物。实验结果表明，所述多肽衍生物在保持生物活性的同时半衰期显著延长。本发明还公开了所述多肽衍生物的制备方法，及其在治疗中的作用。

USPTO Abstract

本发明提供了多肽衍生物及其制备方法。具体地，本发明提供了一种多肽衍生物。实验结果表明，所述多肽衍生物在保持生物活性的同时半衰期显著延长。本发明还公开了所述多肽衍生物的制备方法，及其在治疗中的作用。

Drugs covered by this patent

Patent Metadata

Patent number
CN111909256A
Jurisdiction
CN
Classification
—
Expires
2020-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Ningbo Kunpeng Biotech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.